CRISPRO · KNOWLEDGE BASE

Back to All Articles

Abstract B065: Stage-aware CRISPR design for brain metastasis interception: Multi-modal validation of BBB extravasation and CNS colonization targets

By CrisPRO Research|May 21, 2026
Abstract B065: Stage-aware CRISPR design for brain metastasis interception: Multi-modal validation of BBB extravasation and CNS colonization targets

F Kiani, SA Allah · Cancer Research 86 (6_Supplement), B065-B065, 2026

Abstract B065: Stage-aware CRISPR design for brain metastasis interception: Multi-modal validation of BBB extravasation and CNS colonization targets

Stage-aware CRISPR designs prioritize blood–brain barrier extravasation and CNS colonization targets for brain metastasis. Multi-modal models validate target sets across metastatic stages before therapeutic design.

F Kiani, SA Allah

Cancer Research 86 (6_Supplement), B065-B065, 2026

Published abstract: https://scholar.google.com/citations?view_op=view_citation&hl=en&user=HrO6JwkAAAAJ&citation_for_view=HrO6JwkAAAAJ:J_g5lzvAfSwC

Categories

Conference Abstracts

Next article

All articles
Lung Cancer Brain Metastasis. Here's What We Found — and Why It Matters for a Cure.

Lung Cancer Brain Metastasis. Here's What We Found — and Why It Matters for a Cure.

Approximately 20–40% of non-small cell lung cancer (NSCLC) patients develop brain metastases — tumors that have broken away from the primary site, crossed the blood-brain barrier, and colonized the most protected organ in the human body. Once that happens, median survival drops to months.

Read next